Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATCH: Hydroxychloroquine to Prevent Congenital Heart Block
NCT01379573Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 2011
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in Congenital Heart Block (CHB), sponsored by NYU Langone Health. Started Jan 2011; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
Congenital Heart Block (CHB)
Beyond the preview
Go deeper on NCT01379573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379573.